Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 145725, 7 pages
http://dx.doi.org/10.1155/2013/145725
Research Article

Association of Human Leukocyte Antigen Class I Polymorphism with Spontaneous Clearance of Hepatitis B Surface Antigen in Qidong Han Population

1Medical School, Ministry of Education, Southeast University, Nanjing, Jiangsu 210009, China
2Key Laboratory of Developmental Genes and Human Disease, Ministry of Education, Southeast University, Nanjing, Jiangsu 210096, China
3The Second Affiliated Hospital of Southeast University, Nanjing, Jiangsu 210008, China

Received 29 May 2013; Revised 27 September 2013; Accepted 29 September 2013

Academic Editor: Basak Kayhan

Copyright © 2013 Fengqin Miao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Lavanchy, “Hepatitis B virus epidemiology, disease burden, treatment, arid current and emerging prevention and control measures,” Journal of Viral Hepatitis, vol. 11, no. 2, pp. 97–107, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organization and B. Hepatitis, “World Health Organization Fact Sheet No. 204,” WHO Web site, 2008.
  3. X. C. Guo and Y. Q. Wu, “A review: progress of prevention and control on viral hepatitis in China,” Biomedical and Environmental Sciences, vol. 12, no. 3, pp. 227–232, 1999. View at Google Scholar
  4. D. Ganem and A. M. Prince, “Hepatitis B virus infection—natural history and clinical consequences,” The New England Journal of Medicine, vol. 350, no. 11, pp. 1118–1129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-J. Chu and A. S. F. Lok, “Clinical significance of hepatitis B virus genotypes,” Hepatology, vol. 35, no. 5, pp. 1274–1276, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. F.-S. Wang, “Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection,” World Journal of Gastroenterology, vol. 9, no. 4, pp. 641–644, 2003. View at Google Scholar · View at Scopus
  7. M. Thursz, “Genetic susceptibility in chronic viral hepatitis,” Antiviral Research, vol. 52, no. 2, pp. 113–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Frodsham and A. V. S. Hill, “Genetics of infectious diseases,” Human Molecular Genetics, vol. 13, no. 2, pp. R187–R194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. F. V. Chisari and C. Ferrari, “Hepatitis B virus immunopathology,” Springer Seminars in Immunopathology, vol. 17, no. 2-3, pp. 261–281, 1995. View at Google Scholar · View at Scopus
  10. Y. F. Wu, L. Y. Wang, T. D. Lee et al., “HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan,” Journal of Medical Virology, vol. 72, no. 1, pp. 17–25, 2004. View at Google Scholar
  11. C. L. Thio, D. L. Thomas, P. Karacki et al., “Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection,” Journal of Virology, vol. 77, no. 22, pp. 12083–12087, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. P. P. J. Dunn, S. T. Cox, and A.-M. Little, “Sequencing protocols for detection of HLA class I polymorphism,” Methods in Molecular Biology, vol. 210, pp. 191–222, 2003. View at Google Scholar · View at Scopus
  13. H. Sun, F. Miao, N. Pan, Y. Shen, W. Xie, and J. Zhang, “Identification of a novel HLA-C allele, C*12:10:02, in a Chinese individual,” Tissue Antigens, vol. 76, no. 5, pp. 424–425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Miao, H. Sun, N. Pan, Y. Shen, W. Xie, and J. Zhang, “Two novel HLA class I alleles, HLA-B*40:122 and HLA-B*40:127,” Tissue Antigens, vol. 77, no. 2, pp. 156–157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. McMichael and P. Klenerman, “HIV/AIDS: HLA leaves its footprints on HIV,” Science, vol. 296, no. 5572, pp. 1410–1411, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. A. T. Tan, S. Koh, V. Goh, and A. Bertoletti, “Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective,” Journal of Gastroenterology and Hepatology, vol. 23, no. 6, pp. 833–843, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Y. Xu, J. Y. Yu, Y. W. Zhong et al., “Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus,” International Journal of Biological Sciences, vol. 4, no. 2, pp. 111–115, 2008. View at Google Scholar
  18. G. Yang, J. Liu, S. Han et al., “Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China,” Tissue Antigens, vol. 69, no. 2, pp. 170–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Moretta and A. Moretta, “Unravelling natural killer cell function: triggering and inhibitory human NK receptors,” EMBO Journal, vol. 23, no. 2, pp. 255–259, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Castriconi, C. Cantoni, M. D. Chiesa et al., “Transforming growth factor β1 inhibits expression of NKP30 and NKG2d receptors: consequences for the NK-mediated killing of dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 4120–4125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. V. M. Braud, H. Aldemir, B. Breart, and W. G. Ferlin, “Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8+ T cells,” Trends in Immunology, vol. 24, no. 4, pp. 162–164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Moser, J. Gibbs, P. E. Jensen, and A. E. Lukacher, “CD94-NKG2A receptors regulate antiviral CD8+ T cell responses,” Nature Immunology, vol. 3, no. 2, pp. 189–195, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. S. I. Khakoo, C. L. Thio, M. P. Martin et al., “HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection,” Science, vol. 305, no. 5685, pp. 872–874, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. Martin, X. Gao, J.-H. Lee et al., “Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS,” Nature Genetics, vol. 31, no. 4, pp. 429–434, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. P. Martin, Y. Qi, X. Gao et al., “Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1,” Nature Genetics, vol. 39, no. 6, pp. 733–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Carrington, S. Wang, M. P. Martin et al., “Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci,” Journal of Experimental Medicine, vol. 201, no. 7, pp. 1069–1075, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. López-Botet, A. Angulo, and M. Gumá, “Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection,” Tissue Antigens, vol. 63, no. 3, pp. 195–203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Gao, Y. Jiao, L. Wang et al., “Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B,” Clinical Immunology, vol. 137, no. 1, pp. 139–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Pan, W. Jiang, H. Sun et al., “KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study,” PLoS ONE, vol. 6, no. 10, Article ID e25682, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. L. L. Lanier, “NK cell recognition,” Annual Review of Immunology, vol. 23, pp. 225–274, 2005. View at Google Scholar
  31. M. A. Karan, N. E. Tascioglu, A. O. Ozturk, S. Palanduz, and M. Carin, “The role of HLA antigens in chronic hepatitis B virus infection,” Journal of the Pakistan Medical Association, vol. 52, no. 6, pp. 253–256, 2002. View at Google Scholar · View at Scopus
  32. A. Albayrak, M. Ertek, M. A. Tasyaran, and I. Pirim, “Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey,” Biochemical Genetics, vol. 49, no. 3-4, pp. 258–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Ramezani, M. R. Hasanjani Roshan, E. Kalantar et al., “Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection,” Journal of Gastroenterology and Hepatology, vol. 23, no. 11, pp. 1716–1721, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S.-H. Hwang, Y.-H. Sohn, H.-B. Oh et al., “Human-leukocyte antigen alleles and haplotypes associated with chronicity of hepatitis B virus infection in Koreans,” Archives of Pathology and Laboratory Medicine, vol. 131, no. 1, pp. 117–121, 2007. View at Google Scholar · View at Scopus